<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2825">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04692129</url>
  </required_header>
  <id_info>
    <org_study_id>2020/591</org_study_id>
    <nct_id>NCT04692129</nct_id>
  </id_info>
  <brief_title>Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients</brief_title>
  <acronym>PRONECOVID19</acronym>
  <official_title>Short-term Effects of Prone Positioning on Tissue Oxygen Saturation, Measured by Near-infrared Spectroscopy, in COVID-19 Patients With Acute Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de Ciències Fotòniques (ICFO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre de Recerca Matemàtica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute of Physics University of Campinas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to monitor short-term changes in tissue oxygen saturation and&#xD;
      local blood flow as results of changing from supine to prone position in ARDS COVID-19&#xD;
      patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining consent to participate in the study, the subjects included in the study will&#xD;
      undergo a baseline 15-minute measurement of tissue oxygen saturation (StO2) measured&#xD;
      non-invasively on the forearm by means of near-infrared spectroscopy (NIRS). Once a baseline&#xD;
      stable StO2 value is obtained, a provocative test, consisting of a transient vascular&#xD;
      occlusion, will be performed. The test will allow the obtention of a local metabolic rate,&#xD;
      and a StO2 recovery rate after the ischemic stimulus.&#xD;
&#xD;
      Tissue oxygenation measurements will be performed in supine position, immediately before&#xD;
      changing to prone positioning, and repeated after 20 minutes of stabilization, once in prone&#xD;
      position.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 29, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in tissue oxygenation (StO2)</measure>
    <time_frame>20 minutes</time_frame>
    <description>Tissue oxygenation is measured as % of oxyhemoglobin over total hemoglobin content in the sensed area (skeletal muscle)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in local hemoglobin content (THC)</measure>
    <time_frame>20 minutes</time_frame>
    <description>THC is measured as microMols</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare changes in tissue oxygenation (StO2) and arterial oxygenation (SaO2)</measure>
    <time_frame>20 minutes</time_frame>
    <description>Arterial oxygenation (SaO2) is obtained from blood gas analysis, from an arterial blood sample, while StO2 is derived from the sensed tissue, by means of NIRS/DCS technology</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid19</condition>
  <condition>ARDS, Human</condition>
  <eligibility>
    <study_pop>
      <textblock>
        COVID-19 patients with severe hypoxemia, under mechanical ventilation, and requiring prone&#xD;
        positioning as a rescue therapy for hypoxemia management&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 patients admitted in the ICU receiving invasive mechanical ventilation and&#xD;
             requiring prone positioning for severe hypoxemia management, as decided by the medical&#xD;
             team&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe peripheral vasculopathy&#xD;
&#xD;
          -  Raynaud's syndrome&#xD;
&#xD;
          -  Skin lesions/trauma in upper limbs interfering the placement of the NIRS probe and/or&#xD;
             the occlusion tourniquet&#xD;
&#xD;
          -  Deep venous thrombosis in the upper limbs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaume Mesquida</last_name>
    <role>Principal Investigator</role>
    <affiliation>Parc Taulí Hospital Universitari</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaume Mesquida, MD, PhD</last_name>
    <phone>+34 937231010</phone>
    <phone_ext>21155</phone_ext>
    <email>jmesquida@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de Clñinicas da UNICAMP</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rickson Coelho Mesquita</last_name>
      <email>rickson@ifi.unicamp.br</email>
    </contact>
    <investigator>
      <last_name>Rodrigo Forti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de México</name>
      <address>
        <city>México</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Argelia Pérez Pacheco</last_name>
      <email>argeliapp@ciencias.unam.mx</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parc Taulí Hospital Universitari</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaume Mesquida</last_name>
      <email>jmesquida@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>Alba Caballer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Espinal</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic i Provincial de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Castro</last_name>
      <email>pcastro@clinic.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Salut Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Marin Corral, MD, PhD</last_name>
      <email>jmarin@imim.es</email>
    </contact>
    <investigator>
      <last_name>Clara Vila</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricard Ferrer</last_name>
      <email>r.ferrer@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Marina García de Acilu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Mexico</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 30, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2020</study_first_posted>
  <last_update_submitted>January 27, 2021</last_update_submitted>
  <last_update_submitted_qc>January 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Jaume Mesquida</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Tissue oxygenation</keyword>
  <keyword>ARDS</keyword>
  <keyword>Prone position</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

